Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 2Phase 2/3 2Phase 1/2 2Phase 1 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 2Neoplasms 2Sturge-Weber Syndrome 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Leukemia, Myeloid, Acute 1Gastroenteropancreatic Neuroendocrine Tumors 1Epilepsy 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1

Interventions

Sirolimus 2Everolimus 2Vigabatrin 1Fluid Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Tuberous Sclerosis × Sirolimus × Clear all
NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Unknown
60 enrolled

Epilepsy, Neoplasms, Tuberous Sclerosis

NCT03826628 2023-09-08

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

Dermatology Specialties Limited Partnership

Phase 2/3 Completed
107 enrolled 24 charts

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡